Facebook Enhances Antidepressant Pharmacotherapy Effects
Treatment-resistant major depressive disorder (TR-MDD) is a complex condition, with very low remission rates. In recent years some studies have been conducted on the implementation of cognitive behavioral therapy and psychodynamic psychotherapy interventions via the Internet to MDD patients, and res...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2014/892048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849405000990588928 |
|---|---|
| author | Jorge Mota Pereira |
| author_facet | Jorge Mota Pereira |
| author_sort | Jorge Mota Pereira |
| collection | DOAJ |
| description | Treatment-resistant major depressive disorder (TR-MDD) is a complex condition, with very low remission rates. In recent years some studies have been conducted on the implementation of cognitive behavioral therapy and psychodynamic psychotherapy interventions via the Internet to MDD patients, and results have been promising. However, there have been no studies in patients with TR-MDD nor with the use of Facebook with the psychiatrist as “friend.” 60 TR-MDD patients were randomized to one of three groups: Facebook group with psychiatrist as “friend,” Facebook group without psychiatrist as “friend,” and control group (no Facebook use). Both Facebook groups spent at least 1 hour/day on Facebook, 7 days/week, during the 3 months. All patients maintained their usual pharmacotherapy. All participants were evaluated at baseline and at 1, 2, and 3 months for depressive symptoms using HAD17 and BDI-II. Results show that both Facebook groups had a decrease on HADM17 and BDI-II scores as well as higher remission and response rates than the control group, with better results if the psychiatrist was a “friend” on Facebook. Therefore, in TR-MDD, Facebook can be used as an effective enhancement therapy, adjuvant to pharmacological therapy with regular consultations, especially if the psychiatrist is the patient’s online “friend.” |
| format | Article |
| id | doaj-art-4904ca8ec1d144a39a6eba4c13cb6404 |
| institution | Kabale University |
| issn | 2356-6140 1537-744X |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-4904ca8ec1d144a39a6eba4c13cb64042025-08-20T03:36:47ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/892048892048Facebook Enhances Antidepressant Pharmacotherapy EffectsJorge Mota Pereira0Clínica Médico-Psiquiátrica da Ordem, Rua Gonçalo Cristóvão, No. 347, Sala 202, 4000-270 Porto, PortugalTreatment-resistant major depressive disorder (TR-MDD) is a complex condition, with very low remission rates. In recent years some studies have been conducted on the implementation of cognitive behavioral therapy and psychodynamic psychotherapy interventions via the Internet to MDD patients, and results have been promising. However, there have been no studies in patients with TR-MDD nor with the use of Facebook with the psychiatrist as “friend.” 60 TR-MDD patients were randomized to one of three groups: Facebook group with psychiatrist as “friend,” Facebook group without psychiatrist as “friend,” and control group (no Facebook use). Both Facebook groups spent at least 1 hour/day on Facebook, 7 days/week, during the 3 months. All patients maintained their usual pharmacotherapy. All participants were evaluated at baseline and at 1, 2, and 3 months for depressive symptoms using HAD17 and BDI-II. Results show that both Facebook groups had a decrease on HADM17 and BDI-II scores as well as higher remission and response rates than the control group, with better results if the psychiatrist was a “friend” on Facebook. Therefore, in TR-MDD, Facebook can be used as an effective enhancement therapy, adjuvant to pharmacological therapy with regular consultations, especially if the psychiatrist is the patient’s online “friend.”http://dx.doi.org/10.1155/2014/892048 |
| spellingShingle | Jorge Mota Pereira Facebook Enhances Antidepressant Pharmacotherapy Effects The Scientific World Journal |
| title | Facebook Enhances Antidepressant Pharmacotherapy Effects |
| title_full | Facebook Enhances Antidepressant Pharmacotherapy Effects |
| title_fullStr | Facebook Enhances Antidepressant Pharmacotherapy Effects |
| title_full_unstemmed | Facebook Enhances Antidepressant Pharmacotherapy Effects |
| title_short | Facebook Enhances Antidepressant Pharmacotherapy Effects |
| title_sort | facebook enhances antidepressant pharmacotherapy effects |
| url | http://dx.doi.org/10.1155/2014/892048 |
| work_keys_str_mv | AT jorgemotapereira facebookenhancesantidepressantpharmacotherapyeffects |